Trailing-twelve-month (TTM) revenue is $31.19 Billion with a year-over-year growth of (6.71%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $7,727,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-31 |
| Q4 FY2025Period ended 2025-12-31 | $7,091,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-20 |
| Q1 FY2026Period ended 2026-03-31 | $7,197,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-01 |
| Q2 FY2026Period ended 2026-06-30 | $9,177,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $31,192,000,000 |
Current P/S: $18,776,403,450 market capitalization ÷ $31,192,000,000 TTM revenue = 0.60x.
Market capitalization source: FMP quote. Quote observed 2026-09-25T19:45:19.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $9.18B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-25T19:46:02.596Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Compounding and solutions | $3.2B | $4.1B | $4.2B | $3.7B | $3.6B | $3.5B |
| Intermediates and Derivatives | $2.1B | $3.4B | $4.0B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CHINA | $1.5B | $2.3B | $2.5B | $2.2B | $2.4B | $1.8B |
| FRANCE | $875M | $1.4B | $1.4B | $1.1B |
$31.19B
$31.19 Billion
(6.71%)
vs. $33.44B a year ago (TTM)
+1.67%
5 Year compound annual growth rate
1 Year
(6.71%)
3 Year
(10.15%)
5 Year
+1.67%
10 Year
+0.57%
15 Year
(2.62%)
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $30.15B | ($10.15B) | (25.18%) |
| 2024 | $40.30B | ($805.00M) | (1.96%) |
| 2023 | $41.11B | ($9.34B) | (18.52%) |
| 2022 | $50.45B | +$4.28B | +9.27% |
| 2021 | $46.17B | +$18.42B | +66.37% |
| 2020 |
TTM Growth
(6.71%)
3-Year CAGR
(10.15%)
5-Year CAGR
(2.48%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-25T19:46:02.596Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.7B |
| $1.9B |
| Olefins And Co Products | $2.4B | $5.0B | $4.8B | $3.5B | $3.9B | $4.2B |
|---|
| Oxyfuels And Related Products | $2.3B | $3.6B | $5.5B | $5.6B | $5.1B | $4.8B |
|---|
| Polyethylene | $5.8B | $10.1B | $9.6B | $7.6B | $7.6B | $7.2B |
|---|
| Polypropylene | $4.5B | $8.0B | $6.5B | $5.6B | $6.3B | $5.8B |
|---|
| Refined Products | $4.3B | $7.2B | $11.0B | $9.2B | $8.1B | N/A |
|---|
| $1.2B |
| GERMANY | $2.1B | $3.4B | $3.6B | $2.5B | $2.4B | $2.2B |
|---|
| ITALY | $1.2B | $1.8B | $1.7B | $1.4B | $1.4B | $1.3B |
|---|
| JAPAN | $876M | $1.4B | $2.0B | $1.7B | $1.3B | $1.3B |
|---|
| MEXICO | $1.2B | $1.6B | $2.0B | $1.6B | $1.8B | $1.6B |
|---|
| NETHERLANDS | $785M | $1.4B | $1.2B | $805M | $724M | $731M |
|---|
| Non Reportable Geographical Components | $6.2B | $9.1B | $10.0B | $8.8B | $8.8B | $8.3B |
|---|
| POLAND | $926M | $1.2B | $1.3B | $905M | $923M | $790M |
|---|
| UNITED STATES | $12.1B | $22.5B | $24.8B | $20.0B | $19.5B | $11.1B |
|---|
| $27.75B |
| ($6.97B) |
| (20.08%) |
| 2019 | $34.73B | ($4.28B) | (10.97%) |
| 2018 | $39.00B | +$4.52B | +13.11% |
| 2017 | $34.48B | +$5.30B | +18.16% |
| 2016 | $29.18B | ($3.55B) | (10.85%) |
